A novel human Fc-optimized ICAM-1/CD54 antibody (MSH-TP15e) with potent anti-myeloma activity in vitro and in vivo.

被引：0
|
作者：
Peipp, Matthias [1 ]
Gramatzki, Martin [1 ]
Burger, Renate [1 ]
Klausz, Katja [1 ]
Kellner, Christian [1 ]
Guenther, Andreas [1 ]
机构：
[1] Dept Med 2, Div Stem Cell Transplantat & Immunotherapy, Kiel, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19533
引用
收藏
页数：1
相关论文
共 7 条
  • [1] The Novel ADCC-Optimized Human CD54 (ICAM-1) Antibody MSH-TP15e Has Potent Anti-Myeloma Activity
    Klausz, Katja
    Burger, Renate
    Kellner, Christian
    Guenther, Andreas
    Peipp, Matthias
    Gramatzki, Martin
    BLOOD, 2016, 128 (22)
  • [2] Anti-myeloma activity of the novel ADCC-optimized human CD54 (ICAM-1) antibody MSH-TP15e.
    Klausz, Katja
    Cieker, Michael
    Burger, Renate
    Kellner, Christian
    Guenther, Andreas
    Peipp, Matthias
    Gramatzki, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] The novel ICAM-1/CD54 antibody MSH-TP15, identified by a cell-based phage display screening approach, has potent anti-myeloma activity in vitro and in vivo
    Klausz, K.
    Burger, R.
    Kellner, C.
    Peipp, M.
    Gramatzki, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 201 - 201
  • [4] A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries
    Klausz, Katja
    Cieker, Michael
    Kellner, Christian
    Oberg, Hans-Heinrich
    Kabelitz, Dieter
    Valerius, Thomas
    Burger, Renate
    Gramatzki, Martin
    Peipp, Matthias
    ONCOTARGET, 2017, 8 (44) : 77552 - 77566
  • [5] A Novel ICAM-1/CD54 Antibody Identified By Phage Display with Potent Pre-Clinical Anti-Myeloma Activity
    Klausz, Katja
    Burger, Renate
    Kellner, Christian
    Peipp, Matthias
    Gramatzki, Martin
    BLOOD, 2014, 124 (21)
  • [6] The Fc-optimized anti-ICAM-1 antibody MSH-TP15 Fc-eng. efficiently recruits immune cells and eliminates malignant plasma cells in vitro and in vivo
    Klausz, K.
    Cieker, M.
    Kellner, C.
    Otte, A.
    Roesner, T.
    Valerius, T.
    Peipp, M.
    Gramatzki, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 141 - 141
  • [7] Cell death-inducing ICAM-1 antibody has broad and potent anti-myeloma activity in vivo
    Veitonmaki, Niina
    Hansson, Markus
    Li, Zhan-chun
    Ljungars, Anne
    Danielsson, Lena
    Bjorn, Frendeus
    CANCER RESEARCH, 2011, 71
1